93 related articles for article (PubMed ID: 15358196)
1. MUC1 tyrosine phosphorylation activates the extracellular signal-regulated kinase.
Wang H; Lillehoj EP; Kim KC
Biochem Biophys Res Commun; 2004 Aug; 321(2):448-54. PubMed ID: 15358196
[TBL] [Abstract][Full Text] [Related]
2. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90.
Ren J; Bharti A; Raina D; Chen W; Ahmad R; Kufe D
Oncogene; 2006 Jan; 25(1):20-31. PubMed ID: 16158055
[TBL] [Abstract][Full Text] [Related]
3. Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways.
Thompson EJ; Shanmugam K; Hattrup CL; Kotlarczyk KL; Gutierrez A; Bradley JM; Mukherjee P; Gendler SJ
Mol Cancer Res; 2006 Jul; 4(7):489-97. PubMed ID: 16849524
[TBL] [Abstract][Full Text] [Related]
4. MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells.
Mukherjee P; Tinder TL; Basu GD; Gendler SJ
J Leukoc Biol; 2005 Jan; 77(1):90-9. PubMed ID: 15513966
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
6. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells.
Singh PK; Wen Y; Swanson BJ; Shanmugam K; Kazlauskas A; Cerny RL; Gendler SJ; Hollingsworth MA
Cancer Res; 2007 Jun; 67(11):5201-10. PubMed ID: 17545600
[TBL] [Abstract][Full Text] [Related]
8. Identification of four sites of stimulated tyrosine phosphorylation in the MUC1 cytoplasmic tail.
Wang H; Lillehoj EP; Kim KC
Biochem Biophys Res Commun; 2003 Oct; 310(2):341-6. PubMed ID: 14521915
[TBL] [Abstract][Full Text] [Related]
9. JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin.
Huang Z; Yan DP; Ge BX
Cell Signal; 2008 Nov; 20(11):2002-12. PubMed ID: 18713649
[TBL] [Abstract][Full Text] [Related]
10. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
11. ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1.
Horn G; Gaziel A; Wreschner DH; Smorodinsky NI; Ehrlich M
Exp Cell Res; 2009 May; 315(8):1490-504. PubMed ID: 19245809
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the MAP kinase ERK2 in MUC1 mucin signaling.
Meerzaman D; Shapiro PS; Kim KC
Am J Physiol Lung Cell Mol Physiol; 2001 Jul; 281(1):L86-91. PubMed ID: 11404250
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line.
Kohlgraf KG; Gawron AJ; Higashi M; Meza JL; Burdick MD; Kitajima S; Kelly DL; Caffrey TC; Hollingsworth MA
Cancer Res; 2003 Aug; 63(16):5011-20. PubMed ID: 12941828
[TBL] [Abstract][Full Text] [Related]
15. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
16. Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signaling mechanism.
Rodrigues AR; Pignatelli D; Almeida H; Gouveia AM
Mol Cell Endocrinol; 2009 May; 303(1-2):74-81. PubMed ID: 19428994
[TBL] [Abstract][Full Text] [Related]
17. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
18. Activation of ERK mitogen-activated protein kinase in human cells by the mycotoxin patulin.
Wu TS; Yu FY; Su CC; Kan JC; Chung CP; Liu BH
Toxicol Appl Pharmacol; 2005 Sep; 207(2):103-11. PubMed ID: 16102563
[TBL] [Abstract][Full Text] [Related]
19. Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells.
Cohen M; Meisser A; Haenggeli L; Bischof P
Mol Hum Reprod; 2006 Apr; 12(4):225-32. PubMed ID: 16520344
[TBL] [Abstract][Full Text] [Related]
20. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
McDaneld TG; Spurlock DM
J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
